Alan Nicolle

Alan Nicolle’s background includes work across the fields of consultancy, global CROs, and big pharmaceutical companies before he joined MMS in 2014.

In his current position, Alan is responsible for the strategic leadership and planning of the operational side of the business. His main focus revolves around supporting and developing strategic initiatives, overseeing special projects that are of key importance, and assisting the COO with the creation of both short-term and long-term business goals. Alan collaborates closely with executive leadership and heads of all service lines to ensure alignment with the company’s key priorities. Additionally, he provides support to HR and finance functions when needed, aiming to maintain a successful business operational structure within various global regions.

Alan holds a Postgraduate Diploma in Information Technology and Society, as well as a Bachelor’s degree in Physiology and Biochemistry from the University of Southampton.

Suggested For You

news

May 28th, 2025

MMS Named Finalist for Fierce CRO Award in Excellence in Client Service and Partnership, CEO shortlisted for the CRO Champion Award 

perspectives

May 28th, 2025

A Season of Change: Why the REMS Industry Consortium Matters More Than Ever

perspectives

May 20th, 2025

Navigating FDA OMOR Meetings: A Comprehensive Guide to Type X, Y, and Z Meetings for OTC Drug Sponsors

perspectives

May 6th, 2025

Why Clinical Trial Simulation Is Reshaping Drug Development: A Q&A with Dr. Aiden Flynn

perspectives

April 24th, 2025

How to Derisk Clinical Development with Unified Trial Design and Regulatory Strategy

perspectives

April 8th, 2025

Updated UK Clinical Trial Regulation: The Key Changes and Impact on Development Safety Update Report (DSUR) Requirements

news

April 3rd, 2025

Datacise by MMS Wins 2025 Data Breakthrough Award for Best Data Science Solution

perspectives

March 27th, 2025

Enhancing Drug Safety Through Digital Solutions: Innovative Technologies in FDA REMS Programs

news

March 19th, 2025

MMS REMS-focused Technology bolsters Full-Service REMS Solutions

webinar

April 30th, 2025

Advancing Clinical Development with Innovative Trial Design and Regulatory Strategies

perspectives

March 6th, 2025

Overview of FDA Guidance for Industry on Assessment of Ovarian Toxicity in Premenopausal Adults During Development for Oncologic Products

webinar

March 25th, 2025

Overcoming NDA/BLA Submission Challenges: Practical Strategies for Success